Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 25 citing articles:

Differential Pathogenesis of SARS-CoV-2 Variants of Concern in Human ACE2-Expressing Mice
Janhavi P. Natekar, Heather Pathak, Shannon Stone, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1139-1139
Open Access | Times Cited: 40
Portable Breath-Based Volatile Organic Compound Monitoring for the Detection of COVID-19 During the Circulation of the SARS-CoV-2 Delta Variant and the Transition to the SARS-CoV-2 Omicron Variant
Ruchi Sharma, Wenzhe Zang, Ali Tabartehfarahani, et al.
JAMA Network Open (2023) Vol. 6, Iss. 2, pp. e230982-e230982
Open Access | Times Cited: 21
SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice
Katherine S. Lee, Ting Y. Wong, Brynnan P. Russ, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0273430-e0273430
Open Access | Times Cited: 34
Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences
Alessandra Aiello, Saeid Najafi Fard, Delia Goletti
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
BA.1, BA.2 and BA.2.75 variants show comparable replication kinetics, reduced impact on epithelial barrier and elicit cross-neutralizing antibodies
Janmejay Singh, Anbalagan Anantharaj, Aleksha Panwar, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 2, pp. e1011196-e1011196
Open Access | Times Cited: 14
Virulence Profiles of Wild-Type, P.1 and Delta SARS-CoV-2 Variants in K18-hACE2 Transgenic Mice
Yasmin da Silva Santos, Thaís Helena Martins Gamon, Marcela de Azevedo, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 999-999
Open Access | Times Cited: 10
Soluble Angiotensin-Converting Enzyme 2 Protein Improves Survival and Lowers Viral Titers in Lethal Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection with the Delta Variant
Cosimo Cianfarini, Luise Hassler, Jan Wysocki, et al.
Cells (2024) Vol. 13, Iss. 3, pp. 203-203
Open Access | Times Cited: 3
Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice
Katherine S. Lee, Nathaniel A. Rader, Olivia A. Miller-Stump, et al.
Vaccine (2023) Vol. 41, Iss. 34, pp. 5003-5017
Open Access | Times Cited: 7
Influenza virus strains expressing SARS-CoV-2 receptor binding domain protein confer immunity in K18-hACE2 mice
Nathaniel A. Rader, Katherine S. Lee, Andrea N. Loes, et al.
Vaccine X (2024) Vol. 20, pp. 100543-100543
Open Access | Times Cited: 1
A single-dose intranasal live-attenuated codon deoptimized vaccine provides broad protection against SARS-CoV-2 and its variants
Xiang Liu, Wern Hann Ng, Eva Žusinaite, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
PLK1 inhibition dampens NLRP3 inflammasome–elicited response in inflammatory disease models
Marta Baldrighi, Christian Doreth, Li Yang, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 21
Open Access | Times Cited: 4
Cardiac Transfer of SARS-CoV-2 Spike Protein Circulation Techniques — Medicine Induced Hemodialysis on “Vaccinated” Immune Attacks
Research Article, Yang Pachankis
Biomedical Science and Clinical Research (2023) Vol. 2, Iss. 1
Open Access | Times Cited: 3
Evaluation of the Neutralizing Antibody STE90-C11 against SARS-CoV-2 Delta Infection and Its Recognition of Other Variants of Concerns
Leila Abassi, Federico Bertoglio, Željka Mačak Šafranko, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2153-2153
Open Access | Times Cited: 3
Public health equity in information asymmetry – phenomenological studies upon SARS-CoV-2 supervirus mutation
Yang Pachankis
International Physical Medicine & Rehabilitation Journal (2023) Vol. 8, Iss. 1, pp. 14-18
Open Access | Times Cited: 2
SARS‐CoV‐2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice
Charlie Fricke, Florian Pfaff, Lorenz Ulrich, et al.
European Journal of Immunology (2023) Vol. 53, Iss. 12
Open Access | Times Cited: 2
Omicron induced distinct immune respiratory transcriptomics signatures compared to pre‐existing variants in critically ill COVID‐19 patients
Pierre Bay, Christophe Rodriguez, Stefano Caruso, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 12
Closed Access | Times Cited: 2
A cell-adapted SARS-CoV-2 mutant, showing a deletion in the spike protein spanning the furin cleavage site, has reduced virulence at the lung level in K18-hACE2 mice.
Fabrizia Valleriani, Chiara Di Pancrazio, Massimo Spedicato, et al.
Virology (2024) Vol. 592, pp. 109997-109997
Open Access
SARS-CoV-2 Delta variant induces severe damages in the nasal cavity from the first day post-infection in the Syrian hamster model.
Maxime Fusade-Boyer, A. Gambino, Laetitia Merle-Nguyen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Association between serologically confirmed COVID-19 infection and cognitive functioning in community dwelling older adults
Serena Sabatini, Deborah Pacifico, Frei Anja, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 1
Analysis of SARS-CoV-2 variants from patient specimens in Nevada from October 2020 to August 2021
Shannon Harger Payen, Andrew Gorzalski, Danielle Denise Siao, et al.
Infection Genetics and Evolution (2023) Vol. 111, pp. 105434-105434
Open Access | Times Cited: 1
Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice
Katherine S. Lee, Nathaniel A. Rader, Olivia A. Miller, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
A Soluble ACE2 Protein Improves Survival and Lowers Viral Titers in a Lethal Mouse Model of SARS-CoV-2 Infection with the Delta Variant
Cosimo Cianfarini, Luise Hassler, Jan Wysocki, et al.
(2023)
Open Access | Times Cited: 1
Covid-19 Spike Protein Physiological Pathogens through Vesicular H+-Adenosine Triphosphatase
Yang Pachankis
Journal of Clinical Research and Clinical Trials (2023)
Open Access
Cardiomyopathy Does Not Exacerbate the Severity of Pneumonia Caused by a SARS-CoV-2 Delta Variant in the J2N-k Hamster Model
Kiyoko Iwatsuki‐Horimoto, Mutsumi Ito, Moe Okuda-Hamabata, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2280-2280
Open Access
The Covid-19 and TB Syndemic: Differences and Similarities
Stefan H. E. Kaufmann, Alan Sher, Alex Sigal, et al.
Frontiers research topics (2023)
Open Access
Page 1

Scroll to top